Literature DB >> 22715450

New directions in antiplatelet therapy.

José Luis Ferreiro1, Dominick J Angiolillo.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22715450     DOI: 10.1161/CIRCINTERVENTIONS.111.966176

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  16 in total

Review 1.  Age-Related Changes in Hepatic Function: An Update on Implications for Drug Therapy.

Authors:  Joseph L Tan; Jacques G Eastment; Arjun Poudel; Ruth E Hubbard
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 2.  Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.

Authors:  Ana Lucrecia Marcano; José Luis Ferreiro
Journal:  Curr Atheroscler Rep       Date:  2016-11       Impact factor: 5.113

3.  Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation.

Authors:  José L Ferreiro; Masafumi Ueno; Antonio Tello-Montoliu; Salvatore D Tomasello; Davide Capodanno; Piera Capranzano; Kodlipet Dharmashankar; Andrew Darlington; Bhaloo Desai; Fabiana Rollini; Luis A Guzman; Theodore A Bass; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

Review 4.  Current and future antiplatelet therapies: emphasis on preserving haemostasis.

Authors:  James D McFadyen; Mathieu Schaff; Karlheinz Peter
Journal:  Nat Rev Cardiol       Date:  2018-01-03       Impact factor: 32.419

Review 5.  Role of genetic testing in patients undergoing percutaneous coronary intervention.

Authors:  Jae Youn Moon; Francesco Franchi; Fabiana Rollini; Jose R Rivas Rios; Megha Kureti; Larisa H Cavallari; Dominick J Angiolillo
Journal:  Expert Rev Clin Pharmacol       Date:  2017-10-12       Impact factor: 5.045

6.  Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation.

Authors:  José Luis Ferreiro; José Carlos Sánchez-Salado; Montserrat Gracida; Ana Lucrecia Marcano; Gerard Roura; Albert Ariza; Josep Gómez-Lara; Victoria Lorente; Rafael Romaguera; Sílvia Homs; Guillermo Sánchez-Elvira; Luis Teruel; Kristian Rivera; Silvia Gabriela Sosa; Joan Antoni Gómez-Hospital; Dominick J Angiolillo; Angel Cequier
Journal:  J Cardiovasc Transl Res       Date:  2013-12-21       Impact factor: 4.132

Review 7.  The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis.

Authors:  Evangelos K Oikonomou; Theodoros I Repanas; Christos Papanastasiou; Damianos G Kokkinidis; Michael Miligkos; Attila Feher; Dipti Gupta; Polydoros N Kampaktsis
Journal:  Thromb Res       Date:  2016-09-24       Impact factor: 3.944

Review 8.  Novel antiplatelet agents in acute coronary syndrome.

Authors:  Francesco Franchi; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2014-10-07       Impact factor: 32.419

Review 9.  The evolution of antiplatelet therapy in the treatment of acute coronary syndromes: from aspirin to the present day.

Authors:  Dominick J Angiolillo
Journal:  Drugs       Date:  2012-11-12       Impact factor: 9.546

10.  Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model.

Authors:  James W Reinhardt; Juan de Dios Ruiz Rosado; Jenny C Barker; Yong-Ung Lee; Cameron A Best; Tai Yi; Qiang Zeng; Santiago Partida-Sanchez; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2019-06-10       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.